Day 1 › Friday, 19th September
Poster Session 1
Chairs: F. Albrecht – S. Cattaneo – P. Esposito – M. Marengo – P. Raimondo – I. Riva- M. Thielmann – M. A. Valsecchi
Liver Failure
Preoperative Cytosorb “Bridge” Therapy for Jaundice Due to Direct Hyperbilirubinemia in Pancreatic Head CancerCappellano N, Convertini O, De Luca S, Grasso M, Nanna P, Vittorio A, Vitulli M, Di Masi P, Gabriele F
Castellana Grotte (Italy)
Efficacy of Cytosorb® in the treatment of hyperbilirubinemia in autoimmune cholestatic liver diseaseAquilino E.I, Greco S, Liso G, Gernone C, Raffaele I, Mastropasqua G, Scarabaggio G, Vitobello G
Bisceglie (Italy)
The use of extracorporeal hemadsorption with CytoSorb in liver failure: a case report.Serena G, Riccardi I, Bassi F
Udine (Italy)
CytoSorb® as a Therapeutic Option in Liver Dysfunction and Mixed Jaundice due to drug abuseRizzo G, Ruffino R, Chiofalo S, Rizzo G, Clemente M
Castelvetrano (Italy)
Continuous 48-Hour CytoSorb® Treatment in Multi-Organ Failure, Hyperbilirubinemia, and Haemolytic Anaemia in a Patient with Alcoholic Liver DiseasePiccoli E, Fraggetta G, Alessandro S, Mineo A, Interlandi F
Catania (Italy)
Observational study about hepatic toxinis kinetic and evaluation of organ damage in acute on chronic liver failure (aclf) patients. The BILIVER study: preliminary resultsLaici C, Bartolini F, Valsecchi M, Riva I, Siniscalchi A
Bologna (Italy), Ancona (Italy), Milano (Italy), Bergamo (Italy)
Hemoadsorption in Acute-on-Chronic Liver Failure: Impact on Hemodynamics, Organ Function, and Clinical Outcomes. Some preliminary results from The BILIVER studyValsecchi M, Laici C, Costantini S, Riva I, Siniscalchi A
Milano (Italy), Bologna (Italy), Ancona (Italy), Bergamo (Italy)
Baseline Characteristics of 29 Patients with ACLF ≥2: Interim Analysis of the BILIVER StudyCerchiara P, Cerutti E, Laici C, Valsecchi M, Riva I, Siniscalchi A
Ancona (Italy), Bologna (Italy), Milano (Italy), Bergamo (Italy)
Cytosorb® hemoadsorption as metabolic prehabilitation in hepato-biliary sepsis: a Case of post-ERCP pancreatitis with severe hyperbilirubinemiaGasperini C, Michelagnoli G, Bracciotti G, Bendinelli M, Rastrelli P, Fedi M
Pistoia (Italy)
Use of CytoSorb in the Management of Hyperbilirubinemia in a Patient with Suspected Hemophagocytic Syndrome and Autoimmune Cholestatic HepatitisDavid P, Bruschetta E, Brustia M, Gravellone L, Izzo C, Capurro F, Conte M, Karvela M.E, Ruva C.E
Novara (Italy)
CytoSorb hemoadsorption as a bridging strategy in Acute Liver Failure: A Narrative ReviewSpennati M, Erminio E, Pennacchiotti F, Dimito C, Marangiolo P
Manduria (Italy), Castellaneta (Italy)
Intraoperative Continous Kidney Replacement Therapy (CKRT) Use During Liver TransplantationBrigati F, Parodi A, Falqui V, Andorno E, Porcile E, Di Noto A, Centanaro M, Picciotto D, Gandolfo M.T, Montagnani L, Viazzi F, Esposito P, Conti N
Genova (Italy)


